Markets

Market Nav

News Details

12/02/2026 15:36

Vivanza Biosciences - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligatio

Pursuant to regulation 32 of SEBI (Listing Obligation and Disclosure Requirements, 2015, read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding submission of Statement of Deviation or Variation from proceeds of Public issue/right issue/preferential issue, Qualifed Institutions Placement,(QIP) etc, we hereby confirm that the Company has not raised any further funds by means of Public issue, Rights issue, or preferential Issue, etc. \r\n\r\nHence, the statement of Deviation(s) or Variation(s) is not being provided as it is not applicable to the Company